𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib

✍ Scribed by Brady Stein; B. Douglas Smith

Book ID
113544223
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
898 KB
Volume
32
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Activity and tolerability of nilotinib :
Activity and tolerability of nilotinib : A retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerant
✍ Maya Koren-Michowitz; Philipp le Coutre; Justus Duyster; Christof Scheid; Panayi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 382 KB

## Abstract ## BACKGROUND: Nilotinib is active in imatinib‐resistant and ‐intolerant chronic myeloid leukemia patients and was recently approved for these indications. ## METHODS: Data on the efficacy and safety of nilotinib treatment were collected from 2 phase 2 expanded access clinical trials